Triumph Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $315K | Sell |
2,844
-46
| -2% | -$5.1K | 0.09% | 217 |
|
|
2025
Q1 | $324K | Sell |
2,890
-180
| -6% | -$20.2K | 0.11% | 205 |
|
|
2024
Q4 | $284K | Sell |
3,070
-84
| -3% | -$7.76K | 0.1% | 221 |
|
|
2024
Q3 | $264K | Sell |
3,154
-17,045
| -84% | -$1.43M | 0.09% | 224 |
|
|
2024
Q2 | $1.39M | Buy |
20,199
+12,271
| +155% | +$842K | 0.54% | 39 |
|
|
2024
Q1 | $578K | Buy |
+7,928
| New | +$578K | 0.24% | 104 |
|
|
2023
Q2 | – | Sell |
-2,455
| Closed | -$204K | – | 234 |
|
|
2023
Q1 | $204K | Sell |
2,455
-3
| -0.1% | -$249 | 0.1% | 176 |
|
|
2022
Q4 | $211K | Sell |
2,458
-6,745
| -73% | -$579K | 0.11% | 183 |
|
|
2022
Q3 | $568K | Buy |
9,203
+546
| +6% | +$33.7K | 0.31% | 75 |
|
|
2022
Q2 | $535K | Buy |
8,657
+48
| +0.6% | +$2.97K | 0.28% | 85 |
|
|
2022
Q1 | $512K | Buy |
+8,609
| New | +$512K | 0.22% | 112 |
|